Agios Pharmaceuticals, Inc. (AGIO) stock forecast and price target
Price $31.59 · data as of November 13, 2026
12-month price target
Average target$46.11
Upside / downside+46.0%
Analysts9
ConsensusBuy
Low $32.00Average $46.11High $74.00
Gold marker: average target · white marker: today’s price ($31.59)
Analyst ratings
Strong buy 0Buy 7Hold 3Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-5.56 | +21.9% | $186M |
| Next fiscal year ends December 31, 2027 | $-3.11 | +42.5% | $345M |
| Next quarter ends December 31, 2026 | $-1.09 | +41.0% | $65M |
| Quarter after ends March 31, 2027 | $-0.81 | +52.1% | $71M |
Consensus of the analysts covering Agios Pharmaceuticals, updated daily. In the last 30 days 1 estimates were raised and 1 lowered.
Frequently asked questions
What is the Agios Pharmaceuticals stock price target?
The average 12-month target from 9 analysts is $46.11, 46.0% above the current price of $31.59 Targets range from $32.00 to $74.00.
Is Agios Pharmaceuticals a buy according to analysts?
The consensus rating is “Buy” (7 buy, 3 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Agios Pharmaceuticals expected to earn?
Analysts expect EPS of $-5.56 for the fiscal year ending December 31, 2026 and $-3.11 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.